131 related articles for article (PubMed ID: 35759938)
21. MALAT1 Polymorphisms and Lung Cancer Susceptibility in a Chinese Northeast Han Population.
Tong G; Tong W; He R; Cui Z; Li S; Zhou B; Yin Z
Int J Med Sci; 2022; 19(8):1300-1306. PubMed ID: 35928715
[No Abstract] [Full Text] [Related]
22. Association of polymorphisms in MALAT1 with the risk of esophageal squamous cell carcinoma in a Chinese population.
Qu Y; Shao N; Yang W; Wang J; Cheng Y
Onco Targets Ther; 2019; 12():2495-2503. PubMed ID: 31040692
[TBL] [Abstract][Full Text] [Related]
23. Combined Impacts of Genetic Variants of Long Non-Coding RNA MALAT1 and the Environmental Carcinogen on the Susceptibility to and Progression of Oral Squamous Cell Carcinoma.
Ding YF; Wen YC; Chuang CY; Lin CW; Yang YC; Liu YF; Chang WM; Chang LC; Yang SF; Chien MH
Front Oncol; 2021; 11():684941. PubMed ID: 34268119
[TBL] [Abstract][Full Text] [Related]
24. Association of polymorphisms in MALAT1 with risk of coronary atherosclerotic heart disease in a Chinese population.
Wang G; Li Y; Peng Y; Tang J; Li H
Lipids Health Dis; 2018 Apr; 17(1):75. PubMed ID: 29631611
[TBL] [Abstract][Full Text] [Related]
25. Association of polymorphisms in MALAT1 with the risk of endometrial cancer in Southern Chinese women.
Chen G; Zhang M; Liang Z; Chen S; Chen F; Zhu J; Zhao M; He J; Hua W; Duan P
J Clin Lab Anal; 2020 Apr; 34(4):e23146. PubMed ID: 31880028
[TBL] [Abstract][Full Text] [Related]
26. LncRNA MALAT1 potentiates inflammation disorder in Parkinson's disease.
Yang H
Int J Immunogenet; 2021 Oct; 48(5):419-428. PubMed ID: 34291564
[TBL] [Abstract][Full Text] [Related]
27. The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis.
Wang BG; Lv Z; Ding HX; Fang XX; Wen J; Xu Q; Yuan Y
Gene; 2018 Sep; 670():148-154. PubMed ID: 29803923
[TBL] [Abstract][Full Text] [Related]
28. MALAT1 rs664589 Polymorphism Inhibits Binding to miR-194-5p, Contributing to Colorectal Cancer Risk, Growth, and Metastasis.
Wu S; Sun H; Wang Y; Yang X; Meng Q; Yang H; Zhu H; Tang W; Li X; Aschner M; Chen R
Cancer Res; 2019 Oct; 79(20):5432-5441. PubMed ID: 31311811
[TBL] [Abstract][Full Text] [Related]
29. Association of tagSNPs at lncRNA MALAT-1 with HCC Susceptibility in a Southern Chinese Population.
Ji X; Zhang J; Liu L; Lin Z; Pi L; Lin Z; Tian N; Lin X; Chen S; Yu X; Gao Y
Sci Rep; 2019 Jul; 9(1):10895. PubMed ID: 31350456
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
31. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
[TBL] [Abstract][Full Text] [Related]
32. MALAT1 rs619586 A/G polymorphisms are associated with decreased risk of lung cancer.
Chen M; Cai D; Gu H; Yang J; Fan L
Medicine (Baltimore); 2021 Mar; 100(12):e23716. PubMed ID: 33761627
[TBL] [Abstract][Full Text] [Related]
33. MALAT1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma.
Wang ML; Liu JX
J Cell Physiol; 2020 Feb; 235(2):1700-1710. PubMed ID: 31456244
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma.
Sonohara F; Inokawa Y; Hayashi M; Yamada S; Sugimoto H; Fujii T; Kodera Y; Nomoto S
Sci Rep; 2017 Nov; 7(1):16142. PubMed ID: 29170515
[TBL] [Abstract][Full Text] [Related]
35. The association of polymorphisms in lncRNA-
Yang ML; Huang Z; Wang Q; Chen HH; Ma SN; Wu R; Cai WS
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29511035
[TBL] [Abstract][Full Text] [Related]
36. Association study of genetic variation of lncRNA MALAT1 with carcinogenesis of colorectal cancer.
Zhao K; Jin S; Wei B; Cao S; Xiong Z
Cancer Manag Res; 2018; 10():6257-6261. PubMed ID: 30538572
[TBL] [Abstract][Full Text] [Related]
37. Effects of the lncRNA MALAT1 gene region rs664589 site mutation on acute myocardial infarction in Chinese Han.
Yu H; Tu S; Shen C; Bai X; Sun J; Shi M; Li C; Yuan H
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):119-127. PubMed ID: 38372103
[TBL] [Abstract][Full Text] [Related]
38. lncRNA MALAT1 promotes HCC metastasis through the peripheral vascular infiltration via miRNA-613: a primary study using contrast ultrasound.
Zhou D; Wang Y; Hu H; Liu H; Deng J; Li L; Zheng C
World J Surg Oncol; 2022 Jun; 20(1):203. PubMed ID: 35706002
[TBL] [Abstract][Full Text] [Related]
39. Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer.
Abdi E; Latifi-Navid S
Pathol Res Pract; 2022 Nov; 239():154165. PubMed ID: 36257235
[TBL] [Abstract][Full Text] [Related]
40. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
